BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA to weigh easing limits on unproven peptides favored by RFK Jr. The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics Everyone online is suddenly injecting peptides. But almost nobody understands the scienceor the regulation., The FDA recently shifted several peptides off the Category 2 safety risk list tied to The Unregulated World of Peptides: A Legal Minefield for Providers Holt Law